Steven Prestrelski - Oct 5, 2021 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role: Chief Scientific Officer
Signature: /s/ Beth Hecht, as Attorney-in-Fact
Stock symbol: XERS
Transactions as of: Oct 5, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/5/2021, 05:16 PM
Next filing: Jan 5, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney